<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="the efficacy and safety of various treatments for COVID-19 [36]." exact="Chloroquine" post="phosphate Chloroquine phosphate is an old drug used to"/>
 <result pre="and safety of various treatments for COVID-19 [36]. Chloroquine phosphate" exact="Chloroquine" post="phosphate is an old drug used to treat malaria,"/>
 <result pre="and adequate safety in the treatment of COVID-19-related pneumonia [37]." exact="Chloroquine" post="phosphate was also used against the SARS-CoV and Zika"/>
 <result pre="virus epidemics as an important controlling agent. The role of" exact="chloroquine" post="is to increase the pH of intracellular vacuoles and"/>
 <result pre="thus having an anti-rheumatic response [38]. Other studies reported that" exact="chloroquine" post="has potential activity against various viruses by deceleration of"/>
 <result pre="interfering with cellular SARS-CoV receptor glycosylation [39]. The activity of" exact="chloroquine" post="against viruses and as an anti-inflammatory agent might be"/>
 <result pre="treat individuals with COVID-19 pneumonia. Over the last 70 years," exact="chloroquine" post="has been found to be a cost-effective and safe"/>
 <result pre="be a cost-effective and safe drug [37] and in China," exact="chloroquine" post="phosphate at a dose of 500 mg/day in numerous"/>
 <result pre="shown potential activity against COVID-19. Hence, it is postulated that" exact="chloroquine" post="could be used as a possible treatment for individuals"/>
 <result pre="as a possible treatment for individuals with COVID-19-related pneumonia [40]." exact="Hydroxychloroquine" post="Hydroxychloroquine, an aminoquinoline, is less toxic; with the N-diethyl"/>
 <result pre="an aminoquinoline, is less toxic; with the N-diethyl chain of" exact="chloroquine" post="substituted by an N-hydroxyethyl side chain. This alteration in"/>
 <result pre="side chain. This alteration in the side chain makes the" exact="hydroxychloroquine" post="more soluble than chloroquine. The antiviral activity of hydroxychloroquine"/>
 <result pre="the hydroxychloroquine more soluble than chloroquine. The antiviral activity of" exact="hydroxychloroquine" post="is similar to that of chloroquine; by increasing the"/>
 <result pre="similar to that of chloroquine; by increasing the pH the" exact="hydroxychloroquine" post="affects the activated immune cells and Toll-like receptor-mediated signal"/>
 <result pre="and reducing the production of interleukin-6 (IL-6) [41]. Even though" exact="hydroxychloroquine" post="and chloroquine have the same antimalarial action, hydroxychloroquine is"/>
 <result pre="the production of interleukin-6 (IL-6) [41]. Even though hydroxychloroquine and" exact="chloroquine" post="have the same antimalarial action, hydroxychloroquine is preferred over"/>
 <result pre="Even though hydroxychloroquine and chloroquine have the same antimalarial action," exact="hydroxychloroquine" post="is preferred over chloroquine for its low ocular toxicity"/>
 <result pre="chloroquine have the same antimalarial action, hydroxychloroquine is preferred over" exact="chloroquine" post="for its low ocular toxicity [42]. Prolonged treatment (at"/>
 <result pre="ocular toxicity [42]. Prolonged treatment (at least 5 years) with" exact="hydroxychloroquine" post="may cause retinopathy, which is a dose-limiting adverse effect"/>
 <result pre="body weight [40]. Although in their activity against coronaviruses both" exact="chloroquine" post="and hydroxychloroquine have the same theoretical application, the anti-coronaviral"/>
 <result pre="[40]. Although in their activity against coronaviruses both chloroquine and" exact="hydroxychloroquine" post="have the same theoretical application, the anti-coronaviral activity of"/>
 <result pre="hydroxychloroquine have the same theoretical application, the anti-coronaviral activity of" exact="chloroquine" post="is supported by more clinical data [43]. Availability of"/>
 <result pre="chloroquine is supported by more clinical data [43]. Availability of" exact="hydroxychloroquine" post="and chloroquine is low in some countries, and chloroquine"/>
 <result pre="supported by more clinical data [43]. Availability of hydroxychloroquine and" exact="chloroquine" post="is low in some countries, and chloroquine has a"/>
 <result pre="of hydroxychloroquine and chloroquine is low in some countries, and" exact="chloroquine" post="has a more adverse effect than hydroxychloroquine. For instance,"/>
 <result pre="adverse effect than hydroxychloroquine. For instance, in individuals with COVID-19," exact="chloroquine" post="leads to prolongation of the QT interval when interacting"/>
 <result pre="crucial when unable to treat COVID-19 patients, to consider using" exact="hydroxychloroquine" post="instead of chloroquine. In Iran, it was necessary to"/>
 <result pre="instead of chloroquine. In Iran, it was necessary to use" exact="hydroxychloroquine" post="instead of chloroquine due to scarcity. Hydroxychloroquine hindrance by"/>
 <result pre="In Iran, it was necessary to use hydroxychloroquine instead of" exact="chloroquine" post="due to scarcity. Hydroxychloroquine hindrance by other antiviral agents,"/>
 <result pre="necessary to use hydroxychloroquine instead of chloroquine due to scarcity." exact="Hydroxychloroquine" post="hindrance by other antiviral agents, such as oseltamivir, lopinavir/ritonavir,"/>
 <result pre="etÂ al. conducted a comprehensive meta-analysis on the use of" exact="chloroquine" post="derivatives in COVID-19 patients. It was observed that the"/>
 <result pre="COVID-19 patients. It was observed that the combined therapy of" exact="hydroxychloroquine" post="with azithromycin was more effective than hydroxychloroquine alone and"/>
 <result pre="It was observed that the combined therapy of hydroxychloroquine with" exact="azithromycin" post="was more effective than hydroxychloroquine alone and the combined"/>
 <result pre="combined therapy of hydroxychloroquine with azithromycin was more effective than" exact="hydroxychloroquine" post="alone and the combined therapy was considered more important"/>
 <result pre="therapy [45]. Despite controversy as the virus spreads across borders," exact="chloroquine" post="derivatives are used by physicians on a large scale"/>
 <result pre="The novel pro-drug remdesivir, a nucleotide analogue intracellularly activated to" exact="adenosine" post="triphosphate analogue, which hinders the viral RNA polymerase, was"/>
 <result pre="to treat COVID-19, and further research is needed. Lopinavir and" exact="ritonavir" post="Lopinavir are protease inhibitors that are usually used to"/>
 <result pre="virus infection with and a booster drug ritonavir. Lopinavir and/or" exact="ritonavir" post="have inÂ vitro anti-coronaviral activity; they inhibit the proteases,"/>
 <result pre="polyprotein processing in coronaviruses. InÂ vitro studies have reported that" exact="lopinavir" post="can inhibit SARS-CoV, and the EC50 of lopinavir is"/>
 <result pre="reported that lopinavir can inhibit SARS-CoV, and the EC50 of" exact="lopinavir" post="is acceptable. Against SARS-CoV-2, lopinavir showed efficacy in Vero"/>
 <result pre="SARS-CoV, and the EC50 of lopinavir is acceptable. Against SARS-CoV-2," exact="lopinavir" post="showed efficacy in Vero E6 cells, with an estimated"/>
 <result pre="[56]. In Singapore, five individuals with COVID-19 were treated with" exact="lopinavir" post="and ritonavir within 1â€&quot;3 days of duration, but evidence"/>
 <result pre="Singapore, five individuals with COVID-19 were treated with lopinavir and" exact="ritonavir" post="within 1â€&quot;3 days of duration, but evidence of clinical"/>
 <result pre="integrase protein) and human immunodeficiency virus 1. This confirms that" exact="ivermectin" post="is responsible for inhibiting the nuclear import of integrase"/>
 <result pre="protein and human immunodeficiency virus type-1 replication. Other effects of" exact="ivermectin" post="have been reported, other than the inhibition of the"/>
 <result pre="pseudorabies virus-infected mice [66]. An inÂ vitro study reported that" exact="ivermectin" post="was found to be an inhibitor of SARS-CoV-2. A"/>
 <result pre="and available in most countries [74]. According to new studies," exact="dexamethasone" post="was the first agent to be proven to cause"/>
 <result pre="on various drugs that may help against COVID-19 found that" exact="dexamethasone" post="improves the survival of patients with COVID-19 who are"/>
 <result pre="history, and must consult the official recommendations of WHO for" exact="dexamethasone" post="clinical use, because from time to time drugs are"/>
 <result pre="are approved. It was also explained in the study that" exact="dexamethasone" post="does not help those who are mildly infected with"/>
 <result pre="synthesis Remdesivir PubChem CID:121304016 Image 1 Intravenous COVID-19 A prodrug," exact="adenosine" post="nucleotide analogue, which acts as an RdRp inhibitor 1.76"/>
 <result pre="HIV Inhibition of protease 26.62 Î¼M Yes Viral entry inhibitors" exact="Hydroxychloroquine" post="PubChem CID:3652 Image 4 Orally Antimalarial Increase the endosomal"/>
 <result pre="interference Glycosylation of SARS-CoV (ACE-2) cell receptor 4.51 Î¼M yes" exact="Chloroquine" post="PubChem CID:2719 Image 5 Orally Antimalarial 2.71 Î¼M Immunomodulatory"/>
 <result pre="such as chloroquine, hydroxychloroquine, lopinavir/ritonavir, favipiravir, remdesivir, tociluzimab, nitazoxanide and" exact="ivermectin" post="[92]. We also discuss diagnostic procedure such as molecular"/>
 <result pre="review of early and emerging optionsOpen Forum Infect Dis742020ofaa10532284951 37GaoJ.TianZ.YangX.Breakthrough:" exact="chloroquine" post="phosphate has shown apparent efficacy in treatment of COVID-19"/>
 <result pre="acid receptorsNat Struct Mol Biol26201948148931160783 39PlantoneD.KoudriavtsevaT.Current and future use of" exact="chloroquine" post="and hydroxychloroquine in infectious, immune, neoplastic, and neurological diseases:"/>
 <result pre="Struct Mol Biol26201948148931160783 39PlantoneD.KoudriavtsevaT.Current and future use of chloroquine and" exact="hydroxychloroquine" post="in infectious, immune, neoplastic, and neurological diseases: a mini-reviewClin"/>
 <result pre="neoplastic, and neurological diseases: a mini-reviewClin Drug Invest382018653671 40SavarinoA.BoelaertJ.R.CassoneA.MajoriG.CaudaR.Effects of" exact="chloroquine" post="on viral infections: an old drug against today's diseases?Lancet"/>
 <result pre="dosing per recent ophthalmology guidelinesArthritis Res Ther20201813329976231 42TanY.W.YamW.K.SunJ.ChuJ.J.H.An evaluation of" exact="chloroquine" post="as a broad-acting antiviral against hand, foot and mouth"/>
 <result pre="and mouth diseaseAntivir Res149201814314929175128 43SahraeiZ.ShabaniM.ShokouhiS.SaffaeiA.Aminoquinolines against coronavirus disease 2019 (COVID-19):" exact="chloroquine" post="or hydroxychloroquineInt J Antimicrob Agents55202010594532194152 44MillionM.GautretP.ColsonP.RousselY.DubourgG.ChabriereE.Clinical efficacy of chloroquine"/>
 <result pre="(COVID-19): chloroquine or hydroxychloroquineInt J Antimicrob Agents55202010594532194152 44MillionM.GautretP.ColsonP.RousselY.DubourgG.ChabriereE.Clinical efficacy of" exact="chloroquine" post="derivatives in COVID-19 infection: comparative meta-analysis between the big"/>
 <result pre="and the real world2020100709 45AndreaniJ.Le BideauM.DuflotI.JardotP.RollandC.BoxbergerM.InÂ vitro testing of combined" exact="hydroxychloroquine" post="and azithromycin on SARS-CoV-2 shows synergistic effectMicrob Pathog145202010422832344177 46ColsonP.RolainJ.-M.RaoultD.J.Chloroquine"/>
 <result pre="real world2020100709 45AndreaniJ.Le BideauM.DuflotI.JardotP.RollandC.BoxbergerM.InÂ vitro testing of combined hydroxychloroquine and" exact="azithromycin" post="on SARS-CoV-2 shows synergistic effectMicrob Pathog145202010422832344177 46ColsonP.RolainJ.-M.RaoultD.J.Chloroquine for the"/>
 <result pre="the 2019 novel coronavirus SARS-CoV-2Int J Microb Agents5532020105923 47WangM.CaoR.ZhangL.YangX.LiuJ.XuM.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) inÂ"/>
 <result pre="in SingaporeJAMA32320201488149432125362 58GautretP.LagierJ.C.ParolaP.HoangV.T.MeddebL.SevestreJ.Clinical and microbiological effect of a combination of" exact="hydroxychloroquine" post="and azithromycin in 80 COVID-19 patients with at least"/>
 <result pre="58GautretP.LagierJ.C.ParolaP.HoangV.T.MeddebL.SevestreJ.Clinical and microbiological effect of a combination of hydroxychloroquine and" exact="azithromycin" post="in 80 COVID-19 patients with at least a six-day"/>
 <result pre="treatment of Coronavirus disease 2019Eur Rev Med Pharmacol Sci2420203390339632271456 60ChenC.Y.WangF.L.LinC.C.Chronic" exact="hydroxychloroquine" post="use associated with QT prolongation and refractory ventricular arrhythmiaClin"/>
 <result pre="host antiviral responses and inhibits Ebola virusiScience1920191279129031402258 66CalyL.DruceJ.D.CattonM.G.JansD.A.WagstaffK.M.The FDA-approved drug" exact="ivermectin" post="inhibits the replication of SARS-CoV-2 inÂ vitroAntivir Res178202010478732251768 67KetkarH.YangL.WormserG.P.WangP.Lack"/>
 <result pre="replication of SARS-CoV-2 inÂ vitroAntivir Res178202010478732251768 67KetkarH.YangL.WormserG.P.WangP.Lack of efficacy of" exact="ivermectin" post="for prevention of a lethal Zika virus infection in"/>
 <result pre="Wuhan, ChinaJAMA32320201061106932031570 74WHOWHO, Adapted from WHO welcomes preliminary results about" exact="dexamethasone" post="use in treating critically ill COVID-19 parents16 June 2020WHOGeneva"/>
</results>
